Showing results (1-10 of 183) with videos related to
Sort By:
Pageof 19
Current Opinion in Biotechnology|October 29, 2021
Principles for designing an optimal mRNA lipid nanoparticle vaccineEdo Kon, Uri Elia, Dan PeerProceedings of the National Academy of Sciences of the United States of America|March 4, 2024
Endosomal escape: A bottleneck for LNP-mediated therapeuticsSushmita Chatterjee, Edo Kon, Preeti Sharma, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2019
Therapeutic mRNA delivery to leukocytesYasmin Granot-Matok, Edo Kon, Niels Dammes, et al.Nature Reviews. Clinical Oncology|August 16, 2023
Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospectsEdo Kon, Nitay Ad-El, Inbal Hazan-Halevy, et al.Small (Weinheim an Der Bergstrasse, Germany)|June 23, 2025
On-Chip De Novo Production of mRNA Vaccine in Lipid NanoparticlesShai Zilberzwige-Tal, Aviad Levin, Assaf Ezra, et al.Nature Nanotechnology|August 18, 2022
Nanotechnology-based strategies against SARS-CoV-2 variantsXiangang Huang, Edo Kon, Xuexiang Han, et al.Science Advances|March 8, 2023
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacteriumEdo Kon, Yinon Levy, Uri Elia, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 6, 2019
Immune checkpoint inhibitor combinations: Current efforts and important aspects for successEdo Kon, Itai BenharPharmaceutics|June 11, 2020
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell TransfectionEdo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, et al.Neoplasia (New York, N.Y.)|October 28, 2008
PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cellsUri Elia, Eliezer FlescherPageof 19